News

Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday. Thrive Capital, a venture capital firm, led the ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
The fledgling company was Isomorphic Labs, the secretive artificial intelligence ... While Isomorphic is an independent unit of Google parent Alphabet, Hassabis' dual roles reflect the intertwined ...